These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9084504)

  • 41. Effect of chronic heparin administration on serum lipolytic activity and some aspects of lipid metabolism.
    Goldberg DM; Chajek-Shaul T
    Biochim Biophys Acta; 1990 Nov; 1047(2):103-11. PubMed ID: 2248967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
    Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
    Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A transcription-dependent mechanism, akin to that in adipose tissue, modulates lipoprotein lipase activity in rat heart.
    Wu G; Zhang L; Gupta J; Olivecrona G; Olivecrona T
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E908-15. PubMed ID: 17595214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes.
    Qi D; Kuo KH; Abrahani A; An D; Qi Y; Heung J; Kewalramani G; Pulinilkunnil T; Ghosh S; Innis SM; Rodrigues B
    Cardiovasc Res; 2006 Oct; 72(1):124-33. PubMed ID: 16934788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphatidylinositol-specific phospholipase C releases lipoprotein lipase from the heparin releasable pool in rat heart cell cultures.
    Chajek-Shaul T; Halimi O; Ben-Naim M; Stein O; Stein Y
    Biochim Biophys Acta; 1989 Nov; 1014(2):178-83. PubMed ID: 2554975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long term incubation of cardiac myocytes with oleic acid and very-low density lipoprotein reduces heparin-releasable lipoprotein lipase activity.
    Rodrigues B; Spooner MR; Severson DL
    Mol Cell Biochem; 1992 Oct; 116(1-2):33-7. PubMed ID: 1480152
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparin-releasable and nonreleasable lipoprotein lipase in the perfused rat heart.
    Ben-Zeev O; Schwalb H; Schotz MC
    J Biol Chem; 1981 Oct; 256(20):10550-4. PubMed ID: 7287722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity.
    Davies PJ; Berry SA; Shipley GL; Eckel RH; Hennuyer N; Crombie DL; Ogilvie KM; Peinado-Onsurbe J; Fievet C; Leibowitz MD; Heyman RA; Auwerx J
    Mol Pharmacol; 2001 Feb; 59(2):170-6. PubMed ID: 11160850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of the intravenous administration of homologous albumin on the lipolytic enzyme activity of rabbit blood plasma].
    Soliternova IB; Nikul'cheva NG; Sanches Serrano D
    Vopr Med Khim; 1984; 30(2):87-91. PubMed ID: 6740999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating triglyceride lipolysis facilitates lipoprotein lipase translocation from cardiomyocyte to myocardial endothelial lining.
    Pulinilkunnil T; Qi D; Ghosh S; Cheung C; Yip P; Varghese J; Abrahani A; Brownsey R; Rodrigues B
    Cardiovasc Res; 2003 Sep; 59(3):788-97. PubMed ID: 14499880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner.
    Jong MC; Dahlmans VE; Hofker MH; Havekes LM
    Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):745-50. PubMed ID: 9396715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
    Aalto-Setälä K; Fisher EA; Chen X; Chajek-Shaul T; Hayek T; Zechner R; Walsh A; Ramakrishnan R; Ginsberg HN; Breslow JL
    J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypertriglyceridemia and lipoprotein lipase activity in experimental uremia.
    Kraemer FB; Chen YD; Reaven GM
    Nephron; 1982; 30(3):274-8. PubMed ID: 7099342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nutritional regulation of binding sites for lipoprotein lipase in rat heart.
    Ruge T; Bergö M; Hultin M; Olivecrona G; Olivecrona T
    Am J Physiol Endocrinol Metab; 2000 Feb; 278(2):E211-8. PubMed ID: 10662704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of cold exposure on heart clearing factor lipase and triglyceride utilization in the rat.
    Rogers MP; Robinson DS
    J Lipid Res; 1974 May; 15(3):263-72. PubMed ID: 4827916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced release and synthesis of lipoprotein lipase in rat heart cell cultures exposed to high concentrations of Hepes.
    Friedman G; Chajek-Shaul T; Etienne J; Stein O; Stein Y
    Biochim Biophys Acta; 1987 May; 919(1):1-12. PubMed ID: 3032267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of colchicine on heart lipoprotein lipase.
    Lavín-Palmieri M; Sánchez Serrano D
    Cor Vasa; 1983; 25(2):147-53. PubMed ID: 6872546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased cardiac lipoprotein lipase activity in rats treated chronically with adriamycin.
    Thayer WS
    Life Sci; 1985 Feb; 36(7):635-41. PubMed ID: 3968980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heparin activation of soluble heart lipoprotein lipase.
    Gartner SL; Vahouny GV
    Am J Physiol; 1966 Nov; 211(5):1063-8. PubMed ID: 5924026
    [No Abstract]   [Full Text] [Related]  

  • 60. Changes in plasma lipoproteins during lipolysis in vivo in the hypertriglyceridemic state.
    Karakas SE; Khilnani S; Divens C; Almario R; Jen KL
    Am J Clin Nutr; 1994 Feb; 59(2):378-83. PubMed ID: 8310988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.